HEADER HYDROLASE 10-APR-00 1E0V TITLE XYLANASE 10A FROM SREPTOMYCES LIVIDANS. CELLOBIOSYL-ENZYME TITLE 2 INTERMEDIATE AT 1.7 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDO-1,4-BETA-XYLANASE A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC MODULE, RESIDUES 42-343; COMPND 5 SYNONYM: XYLANASE A, 1,4-BETA-D-XYLAN XYLANOHYDROLASE A, XYLANASE A; COMPND 6 EC: 3.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: GLYCOSYL ENXYME INTERMEDIATE. COVALENT LINK BETWEEN COMPND 9 GLU 236 AND THE SUBSTRATE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES LIVIDANS; SOURCE 3 ORGANISM_TAXID: 1916; SOURCE 4 EXPRESSION_SYSTEM: STREPTOMYCES LIVIDANS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1916; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: IAF 19 KEYWDS XYLANASE, XYLAN DEGRADATION, HYDROLASE, GLYCOSYL-ENZYME INTERMEDIATE EXPDTA X-RAY DIFFRACTION AUTHOR V.DUCROS,S.J.CHARNOCK,U.DEREWENDA,Z.S.DEREWENDA,Z.DAUTER,C.DUPONT, AUTHOR 2 F.SHARECK,R.MOROSOLI,D.KLUEPFEL,G.J.DAVIES REVDAT 6 01-MAY-24 1E0V 1 HETSYN REVDAT 5 29-JUL-20 1E0V 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL LINK SITE ATOM REVDAT 4 05-FEB-14 1E0V 1 HEADER COMPND KEYWDS AUTHOR REVDAT 4 2 1 JRNL REMARK VERSN HETSYN REVDAT 4 3 1 FORMUL MASTER REVDAT 3 24-FEB-09 1E0V 1 VERSN REVDAT 2 25-MAY-01 1E0V 1 JRNL REVDAT 1 05-APR-01 1E0V 0 JRNL AUTH V.DUCROS,S.J.CHARNOCK,U.DEREWENDA,Z.S.DEREWENDA,Z.DAUTER, JRNL AUTH 2 C.DUPONT,F.SHARECK,R.MOROSOLI,D.KLUEPFEL,G.J.DAVIES JRNL TITL SUBSTRATE SPECIFICITY IN GLYCOSIDE HYDROLASE FAMILY 10. JRNL TITL 2 STRUCTURAL AND KINETIC ANALYSIS OF THE STREPTOMYCES LIVIDANS JRNL TITL 3 XYLANASE 10A JRNL REF J.BIOL.CHEM. V. 275 23020 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10930426 JRNL DOI 10.1074/JBC.M000129200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.R.ANDREWS,S.J.CHARNOCK,J.H.LAKEY,G.J.DAVIES,M.CLAEYSSENS, REMARK 1 AUTH 2 W.NERINCKX,M.UNDERWOOD,M.L.SINNOTT,R.A.WARREN,H.J.GILBERT REMARK 1 TITL SUBSTRATE SPECIFICITY IN GLYCOSIDE HYDROLASE FAMILY 10. REMARK 1 TITL 2 TYROSINE 87 AND LEUCINE 314 PLAY A PIVOTAL ROLE IN REMARK 1 TITL 3 DISCRIMINATING BETWEEN GLUCOSE AND XYLOSE BINDING IN THE REMARK 1 TITL 4 PROXIMAL ACTIVE SITE OF PSEUDOMONAS CELLULOSA XYLANASE 10A. REMARK 1 REF J.BIOL.CHEM. V. 275 23027 2000 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 10767281 REMARK 1 DOI 10.1074/JBC.M000128200 REMARK 1 REFERENCE 2 REMARK 1 AUTH U.DEREWENDA,L.SWENSON,R.GREEN,Y.WEI,R.MOROSOLI,F.SHARECK, REMARK 1 AUTH 2 D.KLUEPFEL,Z.S.DEREWENDA REMARK 1 TITL CRYSTAL STRUCTURE, AT 2.6 A RESOLUTION, OF THE STREPTOMYCES REMARK 1 TITL 2 LIVIDANS XYLANASE A, A MEMBER OF THE F FAMILY OF REMARK 1 TITL 3 B-1,4-D-GLYCANASES REMARK 1 REF J.BIOL.CHEM. V. 269 20811 1994 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 8063693 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 28774 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1538 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2314 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 505 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.007 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.022 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.022 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.018 ; 0.030 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.093 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.160 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.240 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : 0.150 ; 0.300 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 3.200 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 12.400; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 26.300; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.059 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.749 ; 5.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.220 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.021 ; 6.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DOUBLY CONFIGURATED DISULPHIDE BOND REMARK 3 BETWEEN CYS168 AND CYS201 THE SIDE CHAIN OF GLN 88, TRP 274 AND REMARK 3 ARG 275 ARE MISSING SINCE THEY ARE TOO DISORDERED TO BE BUILT REMARK 3 INTO DENSITY REMARK 4 REMARK 4 1E0V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-APR-00. REMARK 100 THE DEPOSITION ID IS D_1290004841. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29439 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 36.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.12100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 9.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NATIVE STRUCTURE AT 1.2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLISED WITH 16 % PEG REMARK 280 4000 AS PRECIPITANT,100MM HEPES PH 7.5 AS BUFFER, 10% REMARK 280 ISOPROPANOL, CRYSTAL WERE SOAKED IN PRESENCE OF POWDERED SUBSTR, REMARK 280 PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.93500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.53500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.13500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.53500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.93500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.13500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 303 REMARK 465 ALA A 304 REMARK 465 SER A 305 REMARK 465 SER A 306 REMARK 465 GLU A 307 REMARK 465 PRO A 308 REMARK 465 PRO A 309 REMARK 465 ALA A 310 REMARK 465 ASP A 311 REMARK 465 GLY A 312 REMARK 465 GLY A 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 88 CG CD OE1 NE2 REMARK 470 TRP A 274 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 274 CZ3 CH2 REMARK 470 ARG A 275 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 79 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 CYS A 168 CA - CB - SG ANGL. DEV. = 9.1 DEGREES REMARK 500 CYS A 201 CA - CB - SG ANGL. DEV. = 18.4 DEGREES REMARK 500 GLU A 236 OE1 - CD - OE2 ANGL. DEV. = -10.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 268 -72.38 -99.22 REMARK 500 ARG A 275 34.92 -99.84 REMARK 500 THR A 279 70.42 32.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2012 DISTANCE = 6.86 ANGSTROMS REMARK 525 HOH A2064 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH A2080 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A2196 DISTANCE = 6.14 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XAS RELATED DB: PDB REMARK 900 XYLANASE A REMARK 900 RELATED ID: 1E0W RELATED DB: PDB REMARK 900 XYLANASE 10A FROM SREPTOMYCES LIVIDANS. NATIVE STRUCTURE AT 1.2 REMARK 900 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 1E0X RELATED DB: PDB REMARK 900 XYLANASE 10A FROM SREPTOMYCES LIVIDANS. XYLOBIOSYL-ENZYME REMARK 900 INTERMEDIATE AT 1.65 A REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 41 RESIDUES IN THE DATABASE CORRESPOND REMARK 999 TO THE SIGNAL PEPTIDE. THE NUMBERING USED IN THE PDB FILE REMARK 999 IF AFTER CLEAVAGE OF THE SIGNAL PEPTIDE. REMARK 999 THE LAST 10 RESIDUES ARE INVISIBLE IN DENSITY. DBREF 1E0V A 1 302 UNP P26514 XYNA_STRLI 42 343 SEQRES 1 A 313 ALA GLU SER THR LEU GLY ALA ALA ALA ALA GLN SER GLY SEQRES 2 A 313 ARG TYR PHE GLY THR ALA ILE ALA SER GLY ARG LEU SER SEQRES 3 A 313 ASP SER THR TYR THR SER ILE ALA GLY ARG GLU PHE ASN SEQRES 4 A 313 MET VAL THR ALA GLU ASN GLU MET LYS ILE ASP ALA THR SEQRES 5 A 313 GLU PRO GLN ARG GLY GLN PHE ASN PHE SER SER ALA ASP SEQRES 6 A 313 ARG VAL TYR ASN TRP ALA VAL GLN ASN GLY LYS GLN VAL SEQRES 7 A 313 ARG GLY HIS THR LEU ALA TRP HIS SER GLN GLN PRO GLY SEQRES 8 A 313 TRP MET GLN SER LEU SER GLY SER ALA LEU ARG GLN ALA SEQRES 9 A 313 MET ILE ASP HIS ILE ASN GLY VAL MET ALA HIS TYR LYS SEQRES 10 A 313 GLY LYS ILE VAL GLN TRP ASP VAL VAL ASN GLU ALA PHE SEQRES 11 A 313 ALA ASP GLY SER SER GLY ALA ARG ARG ASP SER ASN LEU SEQRES 12 A 313 GLN ARG SER GLY ASN ASP TRP ILE GLU VAL ALA PHE ARG SEQRES 13 A 313 THR ALA ARG ALA ALA ASP PRO SER ALA LYS LEU CYS TYR SEQRES 14 A 313 ASN ASP TYR ASN VAL GLU ASN TRP THR TRP ALA LYS THR SEQRES 15 A 313 GLN ALA MET TYR ASN MET VAL ARG ASP PHE LYS GLN ARG SEQRES 16 A 313 GLY VAL PRO ILE ASP CYS VAL GLY PHE GLN SER HIS PHE SEQRES 17 A 313 ASN SER GLY SER PRO TYR ASN SER ASN PHE ARG THR THR SEQRES 18 A 313 LEU GLN ASN PHE ALA ALA LEU GLY VAL ASP VAL ALA ILE SEQRES 19 A 313 THR GLU LEU ASP ILE GLN GLY ALA PRO ALA SER THR TYR SEQRES 20 A 313 ALA ASN VAL THR ASN ASP CYS LEU ALA VAL SER ARG CYS SEQRES 21 A 313 LEU GLY ILE THR VAL TRP GLY VAL ARG ASP SER ASP SER SEQRES 22 A 313 TRP ARG SER GLU GLN THR PRO LEU LEU PHE ASN ASN ASP SEQRES 23 A 313 GLY SER LYS LYS ALA ALA TYR THR ALA VAL LEU ASP ALA SEQRES 24 A 313 LEU ASN GLY GLY ALA SER SER GLU PRO PRO ALA ASP GLY SEQRES 25 A 313 GLY HET G2F B 1 11 HET BGC B 2 11 HETNAM G2F 2-DEOXY-2-FLUORO-ALPHA-D-GLUCOPYRANOSE HETNAM BGC BETA-D-GLUCOPYRANOSE HETSYN G2F 2-DEOXY-2-FLUORO-ALPHA-D-GLUCOSE; 2-DEOXY-2-FLUORO-D- HETSYN 2 G2F GLUCOSE; 2-DEOXY-2-FLUORO-GLUCOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 G2F C6 H11 F O5 FORMUL 2 BGC C6 H12 O6 FORMUL 3 HOH *505(H2 O) HELIX 1 1 THR A 4 GLN A 11 1 8 HELIX 2 2 ALA A 21 LEU A 25 5 5 HELIX 3 3 ASP A 27 PHE A 38 1 12 HELIX 4 4 LYS A 48 GLU A 53 1 6 HELIX 5 5 PHE A 61 ASN A 74 1 14 HELIX 6 6 PRO A 90 SER A 95 1 6 HELIX 7 7 SER A 97 TYR A 116 1 20 HELIX 8 8 SER A 141 SER A 146 1 6 HELIX 9 9 ASP A 149 ASP A 162 1 14 HELIX 10 10 TRP A 179 GLY A 196 1 18 HELIX 11 11 ASN A 217 ALA A 227 1 11 HELIX 12 12 PRO A 243 ALA A 256 1 14 HELIX 13 13 ASP A 270 SER A 273 5 4 HELIX 14 14 ARG A 275 THR A 279 5 5 HELIX 15 15 LYS A 290 GLY A 302 1 13 SHEET 1 A 4 GLY A 262 VAL A 265 0 SHEET 2 A 4 TYR A 15 ILE A 20 1 N TYR A 15 O ILE A 263 SHEET 3 A 4 MET A 40 ALA A 43 1 N MET A 40 O THR A 18 SHEET 4 A 4 GLN A 77 ARG A 79 1 N GLN A 77 O VAL A 41 SHEET 1 B 4 ASP A 231 ILE A 234 0 SHEET 2 B 4 CYS A 201 PHE A 204 1 N VAL A 202 O ASP A 231 SHEET 3 B 4 LYS A 166 ASP A 171 1 N TYR A 169 O CYS A 201 SHEET 4 B 4 GLN A 122 ASN A 127 1 N TRP A 123 O LYS A 166 SSBOND 1 CYS A 168 CYS A 201 1555 1555 2.02 SSBOND 2 CYS A 254 CYS A 260 1555 1555 2.03 LINK OE1 GLU A 236 C1 G2F B 1 1555 1555 1.51 LINK O4 G2F B 1 C1 BGC B 2 1555 1555 1.42 CISPEP 1 HIS A 81 THR A 82 0 -0.54 CRYST1 67.870 46.270 87.070 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014734 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021612 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011485 0.00000